Literature DB >> 8528437

Hydroxychloroquine therapy in rheumatic diseases.

R J Anderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8528437

Source DB:  PubMed          Journal:  Bull Rheum Dis        ISSN： 0007-5248


× No keyword cloud information.
  5 in total

1.  Hydroxychloroquine neuromyotoxicity: a case with rapid course and complete recovery.

Authors:  C Vinciguerra; F Sicurelli; A Fioravanti; A Malandrini; C Battisti; A Federico
Journal:  Neurol Sci       Date:  2015-08-11       Impact factor: 3.307

2.  PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.

Authors:  Rui Wang; Lei Xi; Rakesh C Kukreja
Journal:  J Pharmacol Exp Ther       Date:  2017-01-25       Impact factor: 4.030

3.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

4.  Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine.

Authors:  John P O'Laughlin; Parag H Mehta; Brian C Wong
Journal:  Case Rep Cardiol       Date:  2016-07-12

Review 5.  Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?

Authors:  Rakesh C Kukreja; Rui Wang; Saisudha Koka; Anindita Das; Arun Samidurai; Lei Xi
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.